Planet Labs PBC (NYSE:PL) Stock Price Expected to Rise, Wedbush Analyst Says

Planet Labs PBC (NYSE:PL) had its target price upped by research analysts at Wedbush from $30.00 to $40.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Wedbush’s target price would indicate a potential upside of 18.51% from the company’s previous close.

A number of other brokerages also recently commented on PL. Weiss Ratings reiterated a “sell (d-)” rating on shares of Planet Labs PBC in a research report on Thursday, January 22nd. Craig Hallum restated a “buy” rating and set a $30.00 price objective on shares of Planet Labs PBC in a research report on Tuesday, January 13th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $16.40 target price on shares of Planet Labs PBC in a research report on Tuesday, January 20th. Morgan Stanley lifted their price target on shares of Planet Labs PBC from $20.00 to $26.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 13th. Finally, Needham & Company LLC boosted their price target on shares of Planet Labs PBC to $40.00 and gave the company a “buy” rating in a report on Friday. Six investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $26.43.

Planet Labs PBC Stock Performance

NYSE:PL opened at $33.75 on Friday. The firm’s 50-day moving average is $25.17 and its 200-day moving average is $17.92. The company has a market cap of $10.59 billion, a price-to-earnings ratio of -43.27 and a beta of 1.95. The company has a debt-to-equity ratio of 1.28, a quick ratio of 4.00 and a current ratio of 4.00. Planet Labs PBC has a 52-week low of $2.79 and a 52-week high of $36.28.

Planet Labs PBC (NYSE:PL) last released its earnings results on Thursday, March 19th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.43). Planet Labs PBC had a negative net margin of 80.22% and a negative return on equity of 60.21%. The company had revenue of $86.82 million during the quarter, compared to the consensus estimate of $78.17 million. The company’s revenue was up 41.1% compared to the same quarter last year. Equities research analysts anticipate that Planet Labs PBC will post -0.37 earnings per share for the current year.

Insider Activity

In other news, CFO Ashley F. Johnson sold 150,731 shares of the firm’s stock in a transaction that occurred on Wednesday, January 21st. The shares were sold at an average price of $27.01, for a total transaction of $4,071,244.31. Following the completion of the sale, the chief financial officer owned 1,956,101 shares of the company’s stock, valued at approximately $52,834,288.01. This trade represents a 7.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Vijaya Gadde sold 20,000 shares of Planet Labs PBC stock in a transaction that occurred on Thursday, January 22nd. The shares were sold at an average price of $26.77, for a total transaction of $535,400.00. Following the completion of the transaction, the director owned 250,169 shares of the company’s stock, valued at $6,697,024.13. This trade represents a 7.40% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 292,348 shares of company stock valued at $7,323,958 in the last ninety days. 17.53% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Planet Labs PBC

A number of hedge funds and other institutional investors have recently bought and sold shares of PL. Van ECK Associates Corp increased its holdings in Planet Labs PBC by 320.3% during the 4th quarter. Van ECK Associates Corp now owns 7,678,938 shares of the company’s stock valued at $151,429,000 after purchasing an additional 5,851,758 shares in the last quarter. Barclays PLC boosted its stake in Planet Labs PBC by 758.1% in the third quarter. Barclays PLC now owns 3,727,743 shares of the company’s stock worth $48,386,000 after purchasing an additional 3,293,333 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Planet Labs PBC by 265.6% during the third quarter. Invesco Ltd. now owns 3,450,479 shares of the company’s stock worth $44,787,000 after purchasing an additional 2,506,595 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of Planet Labs PBC by 257.5% during the third quarter. Two Sigma Investments LP now owns 2,362,275 shares of the company’s stock worth $30,662,000 after purchasing an additional 1,701,535 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Planet Labs PBC by 9.7% in the third quarter. Vanguard Group Inc. now owns 18,551,697 shares of the company’s stock valued at $240,801,000 after buying an additional 1,637,880 shares in the last quarter. 41.71% of the stock is owned by institutional investors and hedge funds.

Key Planet Labs PBC News

Here are the key news stories impacting Planet Labs PBC this week:

• Positive Sentiment: Q4 revenue beat and stronger FY27 guidance — Planet reported Q4 revenue of $86.8M (above estimates) and issued FY2027 revenue guidance well above Street expectations, underpinning investor optimism about faster growth next year. Press Release
• Positive Sentiment: Stronger govt. demand and expanding backlog — Management highlighted robust government and defense demand (backlog up materially), and governments seeking greater satellite access, which supports recurring revenue visibility. WSJ Coverage
• Positive Sentiment: AI and partner initiatives — Planet emphasized AI-driven product opportunities and partnerships (including work tied to Google/NVIDIA in‑orbit AI themes) that could meaningfully expand civil and commercial demand. MarketWatch
• Positive Sentiment: Analyst upgrade momentum — Multiple firms raised ratings/targets (e.g., Wedbush, Cantor Fitzgerald, Needham boosted PTs toward $40) after the results, adding buy-side validation to the move. Proactive
• Neutral Sentiment: Strong market reaction / option activity — Heavy after‑hours buying and elevated call option volume show speculative and institutional interest, amplifying intraday price moves but not changing fundamentals by itself. Invezz
• Negative Sentiment: Mixed earnings metrics — While revenue beat, reported EPS/GAAP metrics were mixed (some sources note an EPS miss), creating ambiguity between GAAP results and adjusted metrics investors are using to value the story. MarketBeat
• Negative Sentiment: Profitability outlook and heavy investment needs — Management expects to invest (e.g., ramp satellite manufacturing) to fulfill backlog; FY27 adjusted EBITDA guidance implies near‑term margin pressure despite positive FCF last year. Press Release
• Negative Sentiment: Rich valuation — The rally leaves PL with a large market cap and elevated forward multiples, increasing sensitivity to execution risk and any guide-downs. Invezz

Planet Labs PBC Company Profile

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.